Biomed Research International

Scope & Guideline

Empowering global access to groundbreaking biomedical insights.

Introduction

Welcome to the Biomed Research International information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Biomed Research International, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2314-6133
PublisherHINDAWI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationBIOMED RES INT / Biomed Res. Int.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

Biomed Research International aims to contribute to the field of biomedical research by publishing innovative and high-quality research articles that cover a wide range of topics within the biomedical sciences.
  1. Translational Medicine and Clinical Research:
    The journal focuses on bridging laboratory research with clinical applications, facilitating the translation of scientific discoveries into therapeutic interventions.
  2. Molecular and Cellular Biology:
    Research articles often explore cellular mechanisms, gene expression, and molecular pathways involved in health and disease, contributing to a deeper understanding of biological processes.
  3. Public Health and Epidemiology:
    The journal includes studies on public health issues, epidemiological trends, and the impact of socio-economic factors on health outcomes, particularly in developing regions.
  4. Pharmacology and Therapeutics:
    Biomed Research International publishes research on pharmacological agents, their mechanisms of action, and therapeutic potentials, particularly in the context of chronic diseases and cancer.
  5. Innovative Technologies in Medicine:
    The journal highlights advancements in medical technologies, including imaging techniques, telemedicine, and machine learning applications in diagnostics and treatment.
  6. Environmental Health and Toxicology:
    Research related to the effects of environmental factors on health, including studies on toxic substances and their biological impacts, is also a significant area of focus.
Recent publications in Biomed Research International reveal several emerging trends and themes that are gaining prominence in the journal.
  1. Artificial Intelligence and Machine Learning Applications:
    There is a growing trend towards incorporating AI and machine learning techniques in biomedical research, particularly for diagnostics, treatment predictions, and data analysis.
  2. Microbiome Research:
    Research exploring the human microbiome and its impact on health and disease has gained traction, reflecting increasing interest in the gut-brain axis and microbiota-host interactions.
  3. Immunotherapy and Cancer Research:
    The journal has seen a rise in articles focused on immunotherapy, particularly in the context of cancer treatment, highlighting advances in personalized medicine.
  4. Mental Health and Psychosocial Interventions:
    Given the global health crises, studies addressing mental health, particularly related to the COVID-19 pandemic, have become more prevalent.
  5. Regenerative Medicine and Stem Cell Therapy:
    Research in regenerative medicine, including stem cell applications for various diseases, has emerged as a significant area of interest, reflecting advancements in therapeutic techniques.

Declining or Waning

While Biomed Research International has a broad scope, certain areas have seen a decline in research output or interest over recent years.
  1. Traditional Herbal Medicine:
    There has been a noticeable decrease in publications related to traditional herbal medicine, possibly due to a shift towards more evidence-based, mechanistic studies.
  2. In Vitro Studies:
    Research focusing solely on in vitro models has waned in favor of in vivo studies that provide more clinically relevant data.
  3. Basic Science Research:
    There is a declining trend in purely basic science articles without direct clinical applications, as the journal emphasizes translational research.
  4. Epidemiological Studies on Non-Communicable Diseases:
    While public health remains a focus, specific epidemiological studies on non-communicable diseases are less frequent, likely due to the shift towards more immediate health concerns like infectious diseases.

Similar Journals

Biomedical Research and Therapy

Exploring the forefront of biomedical science and therapy.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

FASEB BioAdvances

Transforming Insights into Impactful Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

Indonesian Biomedical Journal

Connecting Researchers with Open Access Insights
Publisher: PRODIA EDUCATION & RESEARCH INSTISSN: 2355-9179Frequency: 3 issues/year

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

BioMedicine-Taiwan

Shaping the future of medicine through collaboration.
Publisher: DIGITAL COMMONS BEPRESSISSN: 2211-8020Frequency: 4 issues/year

BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.

BIOMEDICAL PAPERS-OLOMOUC

Connecting researchers to shape the future of health.
Publisher: PALACKY UNIV, MEDICAL FACISSN: 1213-8118Frequency: 4 issues/year

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Elevating Research Standards in Brazil and Beyond
Publisher: ASSOC BRAS DIVULG CIENTIFICAISSN: 0100-879XFrequency: 12 issues/year

The BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, published by the ASSOC BRAS DIVULG CIENTIFICA, serves as a vital platform for the dissemination of cutting-edge research in the fields of medicine and biological sciences. With an ISSN of 0100-879X and E-ISSN 1414-431X, this Open Access journal has been championing free access to vital scientific knowledge since 1997. It is indexed in Scopus with notable rankings across various disciplines, including a rank of #131 in General Medicine (79th percentile) and #20 in Pharmacology, Toxicology, and Pharmaceutics (75th percentile). Covering a broad scope of topics, the journal primarily focuses on areas such as biochemistry, biophysics, immunology, neuroscience, and physiology, with a commendable categorization of Q2 and Q3 quartiles for several relevant fields in 2023. Through its commitment to high-quality research and robust peer review processes, the journal not only consolidates its reputation within the academic community but also significantly contributes to the enhancement of scientific knowledge and innovation in Brazil and beyond. Researchers, professionals, and students will find an invaluable resource in this journal, which is pivotal for those looking to stay abreast of the latest developments in medical and biological research.

Journal of Biomedical Research

Advancing Biomedical Frontiers with Every Discovery
Publisher: NANJING MEDICAL UNIVISSN: 1674-8301Frequency: 6 issues/year

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.

Biomedica

Elevating research standards in the life sciences.
Publisher: INST NACIONAL SALUD - ColombiaISSN: 0120-4157Frequency: 4 issues/year

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

Experimental and Therapeutic Medicine

Empowering the medical community with pivotal insights.
Publisher: SPANDIDOS PUBL LTDISSN: 1792-0981Frequency: 12 issues/year

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

Cell Reports Medicine

Pioneering the future of healthcare with cutting-edge insights.
Publisher: CELL PRESSISSN: 2666-3791Frequency: 12 issues/year

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.